Literature DB >> 6350190

The course of cryptococcal capsular polysaccharide antigenemia/human cryptococcal polysaccharide elimination kinetics.

R Eng, H Chmel, M Corrado, S M Smith.   

Abstract

The detection of cryptococcal polysaccharides in the serum is diagnostic of cryptococcosis in the absence of rheumatoid factor. The significance of the continued detection of this antigen in the serum during antifungal therapy is not known. Prolonged antigenemia might indicate ongoing active infection, delayed clearance of the polysaccharides from the blood, or continued release of the polysaccharide antigens from a reservoir of nonviable organisms. In seven cases the cryptococcosis with prolonged and high levels of cryptococcal polysaccharide antigenemia, the courses of antigenemia were determined. During the convalescent phase, the T 1/2's were approximately 48 hours for the antigen clearance in all the cases studied. The polysaccharide antigens recovered from the serum of one patient had molecular weights of greater than 200,000 daltons. In rabbits, a single intravenous injection of cryptococcal capsular polysaccharides showed a similarly slow clearance of the antigen with a T 1/2 of approximately 24 to 48 hours. These data suggest that adequately treated cases of cryptococcosis may have a predictable rate of antigen clearance from the serum during convalescence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350190     DOI: 10.1007/bf01641291

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  DETECTION OF CRYPTOCOCCUS NEOFORMANS ANTIGEN IN BODY FLUIDS BY LATEX PARTICLE AGGLUTINATION.

Authors:  N BLOOMFIELD; M A GORDON; D F ELMENDORF
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.

Authors:  J E BENNETT; H F HASENCLEVER
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

4.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

5.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

6.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

7.  Serologic tests in diagnosis and prognosis of cryptococcosis.

Authors:  M A Gordon; D K Vedder
Journal:  JAMA       Date:  1966-09-19       Impact factor: 56.272

8.  Epidemiologic differences among serotypes of Cryptococcus neoformans.

Authors:  J E Bennett; K J Kwon-Chung; D H Howard
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

9.  Serum cryptococcal antigen determination in the presence of rheumatoid factor.

Authors:  R H Eng; A Person
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

10.  Value and interpretation of serological tests for the diagnosis of cryptococcosis.

Authors:  L Kaufman; S Blumer
Journal:  Appl Microbiol       Date:  1968-12
  10 in total
  5 in total

1.  Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor.

Authors:  P L Fidel; J W Murphy
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

2.  Onset and duration of urinary antigen excretion in Legionnaires disease.

Authors:  R B Kohler; W C Winn; L J Wheat
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

3.  Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity.

Authors:  J W Murphy
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

4.  Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells.

Authors:  Pauline M Ellerbroek; Andy I M Hoepelman; Floor Wolbers; Jaap Jan Zwaginga; Frank E J Coenjaerts
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

5.  Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.

Authors:  Z M Dong; J W Murphy
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.